Therapies targeting novel inhibitory and stimulatory immune
checkpoints have been shown to possess substantial therapeutic potential, both
as monotherapies and in combination with other interventions, across multiple
disease interventions
Roots Analysis is pleased to
announce the publication of its recent study, titled, “Next Generation Immune Checkpoint
Inhibitors and Stimulators Market, 2020-2030.”
The
report features an extensive study of the current market landscape, offering an
informed opinion on the likely adoption of these therapies over the next
decade. It features an in-depth analysis, highlighting the capabilities of
various stakeholders engaged in this domain. In addition to other elements, the
study includes:
§
§
§
§
§
§
§
§
- Target
Disease Indication
§
§
§
§
§
§
§
§
§
§
- Target
Immune Checkpoint
§
§
§
§
§
- Mechanism of
Action
§
§
- Therapeutic
Modality
§
§
- Type of
Therapy
§
§
- Route of
Administration
§
§
§
- Key
Geographical Region
§
§
§
Key
companies covered in the
§
§
§
§
§
For
more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html
Other Recent Offerings
1.
2.
3.
About Roots Analysis
Roots
Analysis is one of the fastest growing market research companies, sharing fresh
and independent perspectives in the bio-pharmaceutical industry. The in-depth
research, analysis and insights are driven by an experienced leadership team
which has gained many years of significant experience in this sector. If you’d
like help with your growing business needs, get in touch at
info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav
Chaudhary
+1
(415) 800 3415
gaurav.chaudhary@rootsanalysis.com
